X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19221) 19221
Book Review (5075) 5075
Publication (2087) 2087
Newsletter (1582) 1582
Newspaper Article (965) 965
Book Chapter (268) 268
Book / eBook (143) 143
Government Document (136) 136
Conference Proceeding (108) 108
Magazine Article (76) 76
Trade Publication Article (42) 42
Report (28) 28
Transcript (20) 20
Dissertation (19) 19
Web Resource (14) 14
Reference (5) 5
Data Set (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16700) 16700
animals (12194) 12194
vaccines (10263) 10263
humans (9178) 9178
immunology (8243) 8243
mice (6862) 6862
female (5929) 5929
vaccination (4914) 4914
vaccines, synthetic - immunology (4391) 4391
immunization (4268) 4268
antigens (4003) 4003
vaccine (3933) 3933
medicine, research & experimental (3572) 3572
vaccines, synthetic - administration & dosage (3364) 3364
mice, inbred balb c (3243) 3243
proteins (3169) 3169
male (2663) 2663
health aspects (2608) 2608
research (2598) 2598
immunotherapy (2580) 2580
dendritic cells (2559) 2559
immune response (2481) 2481
infectious diseases (2430) 2430
immunogenicity (2297) 2297
medical research (2290) 2290
infection (2189) 2189
antibodies (2168) 2168
cancer (2134) 2134
viruses (2023) 2023
infections (1990) 1990
immune-responses (1901) 1901
analysis (1877) 1877
microbiology (1872) 1872
immunity (1843) 1843
t cells (1833) 1833
virology (1795) 1795
peptides (1791) 1791
vaccines, synthetic - genetics (1627) 1627
allergy and immunology (1625) 1625
mice, inbred c57bl (1539) 1539
veterinary sciences (1539) 1539
biotechnology & applied microbiology (1529) 1529
adjuvants, immunologic - administration & dosage (1502) 1502
medicine (1422) 1422
pharmacology & pharmacy (1414) 1414
viral vaccines - immunology (1398) 1398
medicine, experimental (1390) 1390
antigen (1365) 1365
immune system (1362) 1362
disease models, animal (1346) 1346
lymphocytes (1339) 1339
dna (1332) 1332
enzyme-linked immunosorbent assay (1331) 1331
adult (1314) 1314
antibodies, viral - blood (1306) 1306
article (1256) 1256
influenza (1244) 1244
prevention (1241) 1241
oncology (1238) 1238
adjuvant (1188) 1188
research article (1187) 1187
care and treatment (1186) 1186
vaccines, dna - immunology (1174) 1174
molecular sequence data (1160) 1160
in-vivo (1152) 1152
t-lymphocytes - immunology (1136) 1136
cancer vaccines (1132) 1132
multidisciplinary sciences (1120) 1120
amino acid sequence (1104) 1104
clinical trials (1104) 1104
cancer vaccines - immunology (1101) 1101
genetic vectors (1088) 1088
studies (1087) 1087
adjuvants (1068) 1068
protection (1060) 1060
immunoglobulin g - blood (1040) 1040
expression (1035) 1035
responses (1034) 1034
virus diseases (1028) 1028
deoxyribonucleic acid--dna (1012) 1012
immune-response (1008) 1008
viral vaccines - administration & dosage (1007) 1007
cytokines (944) 944
lymphocytes t (936) 936
cd8-positive t-lymphocytes - immunology (918) 918
dendritic cells - immunology (916) 916
gene expression (913) 913
protein (911) 911
middle aged (906) 906
administration, oral (885) 885
dna vaccine (884) 884
science (877) 877
t-lymphocytes, cytotoxic - immunology (862) 862
vaccination - methods (857) 857
tumors (849) 849
immunoglobulins (842) 842
antigenic determinants (838) 838
t-cells (837) 837
immunoglobulin g (818) 818
recombinant proteins - immunology (816) 816
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (93) 93
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Robarts - Stacks (6) 6
UofT at Mississauga - Stacks (5) 5
UofT at Scarborough - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Baycrest Hospital - Resident/Client Library (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22185) 22185
Russian (68) 68
Spanish (41) 41
Chinese (35) 35
French (32) 32
German (32) 32
Polish (12) 12
Italian (10) 10
Japanese (9) 9
Czech (4) 4
Dutch (3) 3
Portuguese (3) 3
Danish (2) 2
Norwegian (2) 2
Serbian (2) 2
Turkish (2) 2
Croatian (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 3, pp. 524 - 532
Highlights ► This Phase 1 trial evaluated the safety and immunogenicity of an RSV (F) nanoparticle vaccine. ► The vaccine was well-tolerated and no related... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 52, pp. 7594 - 7600
Highlights ► NDV-3 is safe and generally well-tolerated in healthy adults. ► NDV-3 elicits quick and robust B- and T-cell immune responses. ► A single dose... 
Allergy and Immunology | Vaccine | Als3p | Phase 1 | Candida | First-in-human | Staphylococcus aureus | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | POPULATION | RISK-FACTORS | PROTECTION | IMMUNOLOGY | ACTIVE SURVEILLANCE | HOST-DEFENSE | ENDOCARDITIS | RALS3P-N | BLOOD-STREAM INFECTIONS | EPIDEMIOLOGY | Adjuvants, Immunologic - administration & dosage | Fungal Vaccines - adverse effects | Immunoglobulin G - blood | Humans | Fungal Vaccines - genetics | Fungal Vaccines - immunology | Vaccines, Synthetic - immunology | Adjuvants, Immunologic - adverse effects | Candida albicans - genetics | Fungal Vaccines - administration & dosage | Vaccines, Synthetic - adverse effects | Leukocytes, Mononuclear - immunology | Staphylococcal Vaccines - adverse effects | Adult | Staphylococcal Vaccines - immunology | Alum Compounds - adverse effects | Placebos - administration & dosage | Staphylococcus aureus - genetics | Interleukin-17 - secretion | Interferon-gamma - secretion | Vaccines, Synthetic - genetics | Antibodies, Fungal - blood | Staphylococcal Vaccines - administration & dosage | Candida albicans - immunology | B-Lymphocytes - immunology | Staphylococcal Vaccines - genetics | Immunoglobulin A - blood | Staphylococcus aureus - immunology | T-Lymphocytes - immunology | Vaccines, Synthetic - administration & dosage | Alum Compounds - administration & dosage | Adults | Immune response | Vaccines | T cells | Index Medicus | vaccine | phase 1 | first-in-human
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 3, pp. 313 - 319
Highlights • CMV seronegative girls between 12 and 17 years of age received CMV glycoprotein B (gB) vaccine with MF59 or saline placebo at 0, 1 and 6 months. •... 
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PREVENTION | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ADJUVANT | PLASMA | DNA | DISEASE | CMV INFECTION | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | Index Medicus | adolescent | vaccine | cytomegalovirus
Journal Article
JAMA, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1610 - 1623
Journal Article
Vaccine, ISSN 0264-410X, 12/2017, Volume 35, Issue 51, pp. 7121 - 7126
Typhoid fever remains a serious public health problem with a high impact on toddlers and young children. Vaccines against the Vi capsular polysaccharide are... 
Animal model | Typhoid fever | Vi polysaccharide | O-acetylation | Vaccine | Salmonella Typhi | Polygalacturonic acid | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | CAPSULAR POLYSACCHARIDE | CONJUGATE VACCINES | IMMUNOLOGICAL-PROPERTIES | ANTIGEN | Immunogenicity, Vaccine | Immunoglobulin G - blood | Typhoid-Paratyphoid Vaccines - chemistry | Vaccines, Synthetic - immunology | Immunization, Secondary | Typhoid-Paratyphoid Vaccines - administration & dosage | Acetylation | Antibodies, Bacterial - blood | Disease Models, Animal | Vaccines, Synthetic - chemistry | Polysaccharides, Bacterial - chemistry | Polysaccharides, Bacterial - administration & dosage | Antibody Formation - immunology | Polysaccharides, Bacterial - immunology | Salmonella typhi - immunology | Pectins - chemistry | Pectins - administration & dosage | Pectins - immunology | Animals | Typhoid Fever - microbiology | Immunologic Memory | Typhoid Fever - prevention & control | Mice | Typhoid Fever - immunology | Vaccines, Synthetic - administration & dosage | Typhoid-Paratyphoid Vaccines - immunology | Antigens | Medical research | Polysaccharides | Medicine, Experimental | Vaccines | Acetates | Contamination | Public health | Water-borne diseases | Salmonella | Immunization | Food contamination & poisoning | Antibodies | Licenses | Typhoid | Fever | Molecular weight | Antibody response | Proteins | Acids | Immunogenicity | Bacteria | Children | Index Medicus | vaccine | typhoid fever | animal model | polygalacturonic acid
Journal Article
Infection and Immunity, ISSN 0019-9567, 03/2012, Volume 80, Issue 3, pp. 1222 - 1231
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
FLEXNERI 2A | IMMUNE-RESPONSE | INFECTIOUS DISEASES | HEALTHY-ADULTS | IMMUNOGENICITY | CONJUGATE VACCINES | SAFETY | VOLUNTEERS | LIPOPOLYSACCHARIDE | SHIGA TOXIN | SERUM ANTIBODIES | IMMUNOLOGY | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Shigella flexneri - pathogenicity | Antigens, Bacterial - immunology | Vaccines, Synthetic - immunology | Antigens, Bacterial - genetics | Dysentery, Bacillary - prevention & control | Shigella flexneri - immunology | Escherichia coli Proteins - administration & dosage | Membrane Transport Proteins - genetics | Female | Bacterial Proteins - immunology | Dysentery, Bacillary - immunology | Shigella Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Bacterial Proteins - genetics | Antigens, Bacterial - administration & dosage | Vaccines, Subunit - immunology | Bacterial Proteins - administration & dosage | Enterotoxins - administration & dosage | Animals | Shigella sonnei - pathogenicity | Shigella Vaccines - immunology | Vaccines, Subunit - administration & dosage | Shigella Vaccines - genetics | Bacterial Toxins - administration & dosage | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Membrane Transport Proteins - immunology | Membrane Transport Proteins - administration & dosage | Shigella sonnei - immunology | Index Medicus | Microbial Immunity and Vaccines
Journal Article
Antiviral Research, ISSN 0166-3542, 06/2017, Volume 142, pp. 30 - 36
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2016, Volume 226, pp. 98 - 106
Journal Article